FirsthandHealth
medRxiv PreprintsInternational18 November 2026

α-synuclein seed amplification assay positivity is associated with motor progression in the prodromal stage independent of phenoconversion

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Abstract Background: -Synuclein seed amplification assay (Syn-SAA) has emerged as a promising biomarker for detecting underlying -synuclein pathology and predicting phenoconversion in prodromal Parkinson's disease (PD). However, its association with longitudinal clinical progression during the prodromal stage remains unclear. We investigated whether baseline Syn-SAA status and kinetic parameters were associated with motor and cognitive progression and subsequent phenoconversion in prodromal individuals. Methods: Clinical progression was assessed using the Movement Disorder Society-Sponsored Re
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.